Skip to main content

Abstract

Objective:

Confronting stigma early in life could enhance treatment seeking. In two randomized controlled trials (RCTs), one focused on psychosis and the other on adolescent depression, the efficacy and equivalence of brief social contact–based videos were evaluated and compared with a control condition. The outcomes of interest were changes in illness-related stigma and treatment-seeking intention. The hypotheses were that the intervention videos would show greater efficacy than control conditions and that traditional and selfie videos would demonstrate similar efficacy.

Methods:

Young adults (study 1, N=895) and adolescents (study 2, N=637) were randomly assigned to view intervention videos (in traditional or selfie styles) or to a control condition. In short videos (58–102 seconds), young presenters humanized their illness by emotionally describing their struggles and discussing themes of recovery and hope.

Results:

Repeated-measures analyses of variance and paired t tests showed significant differences in stigma and treatment seeking between the intervention and control groups and similar efficacy of the traditional and selfie videos. Cohen’s d effect sizes ranged from 0.31 to 0.76 for changes in stigma from baseline to 30-day follow-up in study 1 and from 0.13 to 0.47 for changes from baseline to postintervention in study 2.

Conclusions:

The RCTs demonstrated the efficacy of brief videos, both traditional and selfie, in reducing illness-related stigma among young adults and adolescents and in increasing treatment-seeking intention among adolescents. Future studies should explore the effects of brief videos presented by social media influencers on mental health stigma and treatment engagement.

HIGHLIGHTS

Brief social contact–based videos showed efficacy in reducing illness-related stigma among young adults and adolescents and in increasing treatment-seeking intention among adolescents.
The traditional and selfie video styles showed similar efficacy.
Longer, 102-second videos showed similar efficacy to that of shorter, 58-second videos among adolescents.
Depression and schizophrenia often first occur during adolescence and young adulthood, respectively (1). However, approximately 32% of individuals with schizophrenia and 56% of people with depression do not receive treatment (2, 3). Research suggests that barriers to treatment seeking among young people include stigma and embarrassment, poor mental health literacy, and a preference for self-reliance (4). As such, public and internalized stigma or negative attitudes and beliefs may result in avoidance or reduced treatment seeking (5).
Therefore, there is a need for interventions to reduce stigma among young people toward people with mental illness and to increase treatment-seeking intention among youths. Prior research has suggested that social contact–based interventions are effective, regardless of age group (6, 7). These interventions involve interpersonal contact with individuals of a stigmatized group, who share their struggles and recovery, typically in person in classrooms or community centers. Recent studies have shown that video-based interventions have similar efficacy to in-person interventions and are easier to disseminate (8).
However, extant video-based studies have had limitations. First, a recent review found that video interventions last 20–60 minutes or even days (9), whereas younger audiences may prefer shorter content. Second, most studies have included relatively small samples (dozens to hundreds) consisting of narrow and nonrepresentative populations (mostly college students), thus limiting generalizability (810). Third, an emerging trend in treatment toward the use of online platforms has been accelerated by the COVID-19 pandemic, altering content dissemination and increasing remote learning and social media use (1113). Finally, most studies of social contact–based video interventions have assessed stigma immediately postintervention but have lacked follow-up measurement to understand sustained effects (9, 14, 15).
To address these gaps in the literature, we conducted a series of studies (1621) to examine the effect of brief (73 to 100 seconds each) video-based interventions on stigma and treatment-seeking intention. The studies broached several domains, including psychosis-related stigma (1618), depression-related stigma, transphobia, and help seeking (1921). These studies were conducted among national samples of adolescents (ages 14–18) or young adults (ages 18–30) by using several crowdsourcing platforms. Across all studies, we followed the principle of disconfirming stereotypes by balancing discussion of struggles and symptoms with messages of hope and recovery (22). We concluded that brief social contact–based video interventions are effective in reducing stigma and increasing help seeking.
Despite this progress, gaps remain. First, production of the traditional brief video is associated with substantial financial and time costs because it includes interviewing, filming, lighting, sound, and editing processes. Alternatively, young individuals usually film their stories on their own recording devices in selfie style. Selfie-style videos may also appeal more to a young audience because social media influencers often use the medium to connect with their audiences. Second, youths often consume their preferred content on social media platforms (23). Our prior videos lasted 73–100 seconds, longer than the recommended duration limit for Instagram and TikTok of 60 seconds. Two crucial questions emerged from our findings: Would a selfie-style video yield the same effect as a traditionally filmed video? Would shorter versions of these videos yield the same effect?
To answer these questions, we designed two studies, differing in stigma domains, age of participants, and outcome measures, to compare traditional, professionally filmed video (“traditional”), selfie-style video (“selfie”), and control groups in each study. In study 1, young adults ages 18–30 viewed a 75-second video of an individual with psychosis telling her story. The two intervention groups (traditional and selfie) viewed videos with the same content and length and were assessed at baseline, postintervention, and 30-day follow-up. In study 2, adolescents ages 14–18 viewed brief videos of a young individual with depression telling her story. In study 2, we also compared longer and shorter video lengths; the traditional video lasted 102 seconds, whereas the selfie video lasted 58 seconds. Assessments were conducted at baseline and postintervention. We hypothesized that in both studies the intervention videos would show greater efficacy than the control condition and that there would be no difference in efficacy, as assessed with noninferiority analyses, between the traditional and selfie videos.

Methods

Participants and Recruitment

In both studies, recruitment took place in September and October 2021. We chose to focus on adolescents and young adults because of their stage of identity consolidation, a developmental stage characterized by a strong need for autonomy, sense of competence, and social acceptance (24). The age ranges also overlap with the median age of onset of psychosis (young adults) and major depressive disorder (adolescents).

Study 1: young adults.

We recruited participants by using Prolific, a crowdsourcing platform widely used in behavioral and medical research (25). We required participants to be English-speaking U.S. residents and to be 18–30 years old. Participants were compensated $2.20 for study participation. The New York State Psychiatric Institute Institutional Review Board (IRB) approved the project (protocol 8054).

Study 2: adolescents.

Participant recruitment was conducted by using CloudResearch (26), a crowdsourcing platform with demonstrated validity across tasks and countries. We included only English-speaking youths, ages 14–18, living in the United States. Participants were compensated $4.50 for study participation. This study was approved by the Yale Human Investigations Committee, Yale University’s IRB (protocol 2000028980_a).

Intervention

Study 1: young adults.

We compared the efficacy of two brief videos, 75 seconds each, and a nonintervention control. The intervention videos presented the story of an empowered young woman with schizophrenia who described her psychotic illness and her struggles and introduced themes of recovery and hope. One video was filmed in traditional fashion, with support from a documentary video production company and professional lighting, sound, and editing—an intervention proven to be effective in reducing stigma (18). The second video had identical content but was filmed by the participant (i.e., selfie) with her smartphone, with no editing, guidance, or instruction, as if the participant were about to upload her self-made video onto a social media platform. We conducted assessments at baseline, immediately postintervention, and at 30-day follow-up.

Study 2: adolescents.

We compared the efficacy of a traditional, studio-produced, 102-second video, which was previously found to be effective in reducing depression-related stigma and increasing help-seeking intention (19), with that of a shorter (58 seconds), selfie version of the same content. Both videos were based on the same script, with the same 16-year-old adolescent (a professional actress) sharing her personal story of coping with depression and suicidal thoughts and discussing how treatment had helped her. The traditional video was filmed and edited professionally, and the selfie video was filmed by the adolescent herself, with no editing. In the control video, the same adolescent did not discuss mental health, but instead talked about her family and interests. We conducted assessments at baseline and immediately postintervention.

Assessment methodology.

To verify the validity of the study results, we applied several methods in order to exclude invalid participants during data collection. First, in designing the study, we added a timer to ensure that participants had sufficient time to read the instructions and watch the video before the “next” button appeared. Second, we excluded participants who failed our attention verification questions (e.g., “In the following question, please choose the second answer”). Third, we scanned the responses to exclude participants who answered the assessment more than once. Before initiating the survey, participants reviewed an informed consent or assent page (parental consent was waived). We directed individuals who agreed to participate to complete the study survey by using Qualtrics, a secure, online data collection platform.

Instruments

Study 1: young adults.

As in our previous studies (1618), we used a questionnaire to assess public stigma toward people with schizophrenia across five domains (2730): social distance (6 items), stereotyping (4 items), separateness (4 items), social restriction (3 items), and perceived recovery (2 items). Two items assessed whether the participant had a friend or family member with serious mental illness and, if so, their level of intimacy with that individual (31).

Study 2: adolescents.

In study 2, we measured stigma toward depression with the Depression Stigma Scale (DSS) (32) and measured treatment-seeking intention with the General Help-Seeking Questionnaire (GHSQ) (33), similar to our previous studies (1921).

Data Analysis

We calculated sample size, seeking to discriminate at least a medium effect size (Cohen’s d>0.30) between the intervention groups and control group and between intervention groups. By using noninferiority analyses and on the basis of the primary outcomes and expected effect size of 0.30, we determined that a sample size of N=300 for each group in study 1 (young adults) and N=200 for each group in study 2 (adolescents) would provide adequate power (>0.80) to detect α<0.05. We used Pearson’s chi-square test and one-way analysis of variance (ANOVA) to compare demographic variables across study arms. In study 1, repeated-measures ANOVAs were used to compare mean stigma scores on each domain subscale across three study arms (traditional, selfie, and control) and three time points (baseline, postintervention, and 30-day follow-up). One-way ANOVAs were then used to compare changes in stigma scores between baseline and postintervention and between baseline and 30-day follow-up across the three study groups. In study 2, paired t tests were used to compare DSS and GHSQ mean scores from baseline to postintervention within study groups (traditional, selfie, and control), and independent t tests were used to compare between-group changes. For all t tests, we used a Bonferroni correction and considered only results with p<0.01 to be significant (i.e., adjusted for at least 5 comparisons). We conducted all statistical analyses with IBM SPSS, version 28.0.

Results

Sample Characteristics

Study 1: young adults.

After we excluded 47 (5%) participants who failed validity tests, 895 completed the baseline assessment before being randomly assigned at a 1:1:1 ratio to one of the three study groups. Of those, 856 (96%) completed the postintervention assessment, and 640 (72%) completed the 30-day follow-up assessment (a flow diagram is available in the online supplement to this article). Baseline characteristics did not differ between those who did and those who did not complete the assessments, and sociodemographic characteristics did not differ across study groups (Table 1). Mean±SD participant age was 23.9±3.7 years (range 18–30). Almost half of respondents were women (N=428, 48%). A total of 124 (14%) participants self-identified as Black, 124 (14%) as Hispanic, 579 (65%) as White, 113 (13%) as Asian, 7 (1%) as Native American, and 72 (8%) as other.
TABLE 1. Demographic characteristics of young adult (study 1) and adolescent (study 2) study participants
 Traditional videoSelfie videoControl videoTotal   
CharacteristicN%N%N%N%Test statisticadfp
Study 1: young adults
Participants302100304100289100895100   
Age (M±SD years)23.8±3.7 24.0±3.7 24.0±3.7 23.9±3.7 F=.412, 882.680
Female14548138451455042848χ2=7.86.254
Hispanic47164716301012414χ2=8.34.083
Race        χ2=14.110.169
 Black41144214411412414   
 White18662201661926657965   
 Asian42143512361311313   
 Native American621<1071   
 Other279258207728   
Educationb        χ2=13.912.304
 Never completed high school727241182   
 High school graduate49163913401412814   
 Some college credit12241104341063733237   
 Bachelor’s degree953211237903129733   
 Master’s degree227341136139210   
 Doctoral degree5262114223   
Familiar with a person with serious mental illness14849138451194140545χ2=7.24.125
Study 2: adolescents
Participants220100212100205100637100   
Age (M±SD years)17.1±1.1 17.1±1.1 17.1±1.0 17.1±1.1 F=.44, 632.65
Female1095010449964730949χ2=9.68.29
Hispanic44204019432112720χ2=3.14.54
Racec        χ2=10.112.61
 Black49224923442214222   
 White12356112531215935656   
 Asian1572311157538   
 Native American42421191   
 Other2511241122117111   
a
One-way analysis of variance or Pearson chi-square test.
b
Two participants in the traditional video group and two in the selfie video group marked “prefer not to answer.”
c
Four participants in the traditional video group and two in the control video group marked “prefer not to answer.”

Study 2: adolescents.

After we excluded 92 (13%) participants who failed validity tests, 637 were randomly assigned at a 1:1:1 ratio to one of three study arms. Six hundred twenty-five (98%) completed the postintervention assessment (a flow diagram is available in the online supplement). Baseline characteristics did not differ between those who did and those who did not complete the assessments, and sociodemographic characteristics did not differ across study groups (Table 1). Mean participant age was 17.1±1.1 years (range 14–18), and almost half of participants were female (N=309, 49%). A total of 142 (22%) participants self-identified as Black, 127 (20%) as Hispanic, 356 (56%) as White, 53 (8%) as Asian, 9 (1%) as Native American, and 71 (11%) as other.

Intervention Effects

Study 1: young adults.

Study groups significantly differed in outcomes. A 3×3 group × time ANOVA showed that mean stigma scores decreased over time in the two intervention groups across all five stigma domains: social distance (F=25.1, df=2 and 4, p<0.001), stereotyping (F=38.8, df=2 and 4, p<0.001), separateness (F=17.0, df=2 and 4, p<0.001), social restriction (F=22.9, df=2 and 4, p<0.001), and perceived recovery (F=13.2, df=2 and 4, p<0.001). Figure 1 presents the mean score curves of the study groups over time, stratified across each of the five stigma domains, showing that the control group essentially did not demonstrate any change, whereas both intervention groups did. One-way ANOVAs showed a significant between-group change from baseline to postintervention and from baseline to 30-day follow-up across all five stigma domains. Post hoc tests showed that selfie videos were not inferior to traditional videos, with no significant difference between the two but significant differences between each intervention video and the control group. Cohen’s d effect sizes ranged from 0.47 to 0.76 for changes from baseline to postintervention and from 0.31 to 0.76 for changes from baseline to 30-day follow-up.
FIGURE 1. Mean scores measuring domains of stigma toward individuals with schizophrenia among young adults (study 1), by study groupa
aScore ranges: 6–24 for social distance, 4–16 for stereotyping, 4–16 for separateness, 3–12 for social restriction, and 2–8 for perceived recovery, with higher scores indicating greater stigma. One-way analysis of variance: F ranged from 35.4 to 105.3 for changes from baseline to postintervention and from 15.8 to 31.0 for changes from baseline to 30-day follow-up (p<0.001).

Study 2: adolescents.

As in our previous study (19), the study groups significantly differed in outcomes. A univariate ANOVA showed a significant between-group effect for mean DSS total scores between baseline and postintervention (F=8.0, df=1 and 2, p<0.001). Table 2 presents the DSS items and compares baseline with postintervention mean and total scores for the traditional (N=220), selfie (N=212), and control (N=205) groups. Cohen’s d effect sizes ranged from 0.13 to 0.47 for individual DSS items and from 0.24 to 0.26 for DSS total scores. To better understand the outcome differences across study arms, we used independent t tests to compare DSS pre-post changes among the traditional, selfie, and control groups. The traditional (1.4±2.7) and selfie (1.3±3.0) video groups significantly differed from the control video group (0.4±2.1) (t=3.5, df=408, p<0.001 and t=3.6, df=413, p<0.001, respectively), but the traditional and selfie videos did not significantly differ from each other. Table 3 presents the GHSQ scores. We found a significant increase in intention to seek help from a telephone helpline and a decrease in unwillingness to seek help from anyone in both the traditional and selfie video groups. In addition, we found an increase in intention to seek help from a parent in the selfie video group. We found no change in help-seeking intention in the control group. Cohen’s d effect sizes ranged from 0.14 to 0.33.
TABLE 2. Mean Depression Stigma Scale (DSS) scores among adolescents (study 2), by study groupa
 Traditional video (N=220)Selfie video (N=212)Control video (N=205)
 BaselinePostintervention BaselinePostintervention BaselinePostintervention 
DSS itemMSDMSDtbMSDMSDtcMSDMSDtd
1. People with depression could snap out of it if they wanted1.81.11.81.1ns1.91.01.91.1ns1.81.11.81.0ns
2. Depression is a sign of personal weakness1.8*1.0*1.5*.9*5.0*2.0*1.1*1.7*1.0*5.3*2.01.21.91.9ns
3. Depression is not a real medical illness1.5.91.4.9ns1.71.01.6.9ns1.71.01.7.9ns
4. People with depression are dangerous2.21.02.01.0ns2.21.02.11.0ns2.31.02.21.0ns
5. It is best to avoid people with depression, so you don’t become depressed yourself1.7.91.6.8ns1.7.91.6.8ns1.7.81.8.9ns
6. People with depression are unpredictable2.9*1.1*2.6*1.1*4.6*3.0*1.0*2.7*1.1*5.7*2.91.02.81.0ns
7. If I had depression, I would not tell anyone2.9*1.2*2.5*1.2*6.6*3.0*1.2*2.6*1.2*5.6*2.9*1.1*2.7*1.1*4.3*
8. I would not employ someone if I knew they had been depressed1.7.91.6.9ns1.81.01.7.9ns1.7.91.7.8ns
9. I would not vote for a politician if I knew they had been depressed1.8.91.7.9ns1.91.01.91.0ns1.9.91.9.9ns
Total score18.1*5.3*16.7*5.8*6.8*19.1*5.5*17.8*5.8*6.9*18.95.518.45.9ns
a
DSS scores for each item ranged from 1, strongly disagree, to 5, strongly agree, with higher scores indicating greater stigma. Cohen’s d effect sizes ranged from 0.13 to 0.47.
b
df=209 for all values.
c
df=214 for all values.
d
df=199 for all values.
*p<0.001 (paired t test).
TABLE 3. Mean General Help-Seeking Questionnaire (GHSQ) scores among adolescents (study 2), by study groupa
 Traditional video (N=220)Selfie video (N=212)Control video (N=205)
 BaselinePostintervention BaselinePostintervention BaselinePostintervention 
GHSQ itemMSDMSDtbMSDMSDtcMSDMSDtd
1. Intimate partner (e.g., girlfriend, boyfriend)5.21.95.22.0ns5.31.95.41.9ns5.41.85.21.9ns
2. Friend (not related to you)4.81.95.02.0ns4.71.74.81.9ns4.61.64.51.8ns
3. Parent4.02.14.12.2ns4.2*2.1*4.5*2.1*2.4*3.92.13.92.1ns
4. Other family member(s)3.31.93.52.2ns3.52.03.72.1ns3.21.93.22.0ns
5. Mental health professional (e.g., psychologist, social worker, counselor)4.32.14.42.1ns4.32.04.52.0ns4.42.04.22.0ns
6. Telephone helpline (e.g., Lifeline)2.9*1.9*3.3*2.2*3.3*3.0*1.9*3.4*2.1*3.0*3.32.13.52.1ns
7. Doctor or general practitioner3.62.03.92.2ns3.82.03.92.2ns3.82.03.62.0ns
8. Minister or religious leader (e.g., priest, rabbi, chaplain)2.52.02.62.1ns2.72.02.62.0ns2.62.02.62.0ns
9. I would not seek help from anyone3.3*2.1*2.6*2.0*4.9*3.2*2.0*2.7*1.9*2.9*3.52.13.22.0ns
10. I would seek help from another not listed above2.82.02.82.1ns2.92.03.22.2ns3.22.13.22.2ns
a
GHSQ items measured how likely respondents were to seek help from certain individuals. Scores for each item ranged from 1, extremely unlikely, to 7, extremely likely, with higher scores indicating greater help-seeking intention (except for item 9, which was reverse-scored). Cohen’s d effect sizes ranged from 0.14 to 0.33.
b
df=205 for all values.
c
df=214 for all values.
d
df=196 for all values.
*p<0.01 (paired t test).

Discussion

We tested the efficacy of brief videos to reduce stigma toward people with psychosis among 895 young adults (study 1) and to reduce stigma toward people with depression and increase treatment-seeking intention among 637 adolescents (study 2) in two RCTs. As hypothesized, these 58- to 102-second videos, regardless of filming style (traditional or selfie), had significantly greater impact than the control condition in reducing illness-related stigma and increasing treatment-seeking intention. In hopeful, uplifting stories, the intervention videos presented young individuals who struggled with mental illness and successfully engaged in treatment. These findings replicate and extend our previous findings (1621) by showing reduced stigma as a result of viewing shorter videos and videos filmed in a selfie style. Despite a slight rebound after 30 days, these reductions were preserved over time. Our work is consistent with the current literature emphasizing the potency of contact-based interventions in changing young people’s perceptions about mental illness and treatment (7, 10).
We found no difference between the efficacy of traditional and selfie videos, despite differences in study characteristics (e.g., video lengths, presenter with lived experience vs. actor, recruitment methods, assessment tools, study population [young adults vs. adolescents]), thus emphasizing the generalizability of the results. The implications are clear: traditional videos, which require interviewers, photographers, lighting, sound, and editing processes, cost more and take longer to create than selfie videos yet have no advantage over them. In addition, a growing body of literature supports the use of smartphone and selfie videos in medicine. For example, selfie videos are used to detect and monitor symptoms of Parkinson’s disease (34), to intervene to change toothbrushing technique (35), and to develop proficiency in clinical interviewing for medical students (36). In psychiatry, photographs and narratives have been used to communicate the experiences of people with mental illness and engage in a critical dialogue to inform social action (37). For example, Cabassa et al. (38) demonstrated the efficacy of photovoice, a participatory method that empowers people with severe mental illness by giving them cameras to document their experiences of perceived recovery. Tippin and Maranzan (39) showed the efficacy of photovoice-based video in reducing mental illness–related stigma among 303 undergraduate university students.
Selfie-based interventions offer a culturally consonant, technically simpler, and cheaper alternative to traditional videos. Adolescents and young adults create selfie videos anyway—why not harness them to reduce stigma? Although concern has been raised that sharing personal stories through selfies could lead to criticism and shame, especially on social media (40, 41), data point to the potential of social media to combat stigma, raise awareness of mental health problems, and emphasize the societal benefits that can be facilitated via such platforms (42). Young individuals, who already share personal stories on their recording devices using selfie videos, can create content that may reduce stigma. Future intervention research should focus on guiding and instructing adolescents and young adults on how to create stigma-reducing content.
Why explore the optimal length for social contact–based video interventions? We previously showed the efficacy of 73- to 100-second videos in reducing stigma and increasing treatment-seeking intention (1621). Study 2 is the first to directly compare a briefer, 58-second video with a longer intervention video, demonstrating similar efficacy. Brevity has advantages. Leading social media platforms such as Instagram and TikTok, which youths often use (23), recommend limiting video content to 60 seconds. Social media influencers often use selfie videos to connect with the young audiences who follow their opinions and advice. For example, a recent study (43) examined the association between Twitter content of social media influencers and suicide. The authors showed that tweets describing suicide deaths or tragic news stories about suicide may be harmful, whereas those that present suicide as undesirable or preventable may be helpful. These results suggest that social media influencers can positively affect youths’ lives via their social media communications and can be a potential avenue for intervention. Future studies should examine the efficacy of brief videos filmed by a social media influencer and uploaded to a social media platform to reduce mental health stigma and increase engagement with treatment at a larger, population-wide level.
Our study had several limitations. First, findings may be limited to users of crowdsourcing platforms, who might not be fully representative of the general population, thus limiting generalizability. More studies are needed, preferably ones that incorporate social media use. Second, our study assessed only attitudes about stigma and treatment seeking, the reporting of which is subject to social desirability (44). Future studies should measure real-world behaviors and how many participants sought treatment. Last, although one study evaluated 30-day aftereffects, the second study evaluated only the video’s immediate impact. Future research should examine longer-term sustainability of stigma-reduction interventions among adolescents.

Conclusions

These two RCTs replicated and extended our previous findings by showing the positive effect of brief videos, both traditional and selfie style, on reducing stigma associated with psychosis (young adults) or depression (adolescents) and increasing treatment-seeking intention among adolescents. Traditional and selfie videos showed similar efficacy, at a duration of 102 or 58 seconds, respectively (study 2). These findings suggest the potential for the use of brief selfie videos on social media platforms to increase the likelihood that youths will seek services and to improve access to care among young individuals with mental illness. These improvements are especially important given the increased rates of mental illness among youths since the COVID-19 pandemic began. Future studies should explore the effects of brief videos presented by social media influencers on mental health stigma and treatment engagement.

Acknowledgments

The authors thank the video presenters, who shared their stories and contributed to stigma reduction.

Supplementary Material

File (appi.ps.20220168.ds001.pdf)

References

1.
Kessler RC, Amminger GP, Aguilar-Gaxiola S, et al: Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry 2007; 20:359–364
2.
Merikangas KR, He J-P, Burstein M, et al: Service utilization for lifetime mental disorders in US adolescents: results of the National Comorbidity Survey–Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2011; 50:32–45
3.
Kohn R, Saxena S, Levav I, et al: The treatment gap in mental health care. Bull World Health Organ 2004; 82:856–866
4.
Gulliver A, Griffiths KM, Christensen H: Perceived barriers and facilitators to mental health help-seeking in young people: a systematic review. BMC Psychiatry 2010; 10:113
5.
Parcesepe AM, Cabassa LJ: Public stigma of mental illness in the United States: a systematic literature review. Adm Policy Ment Health 2013; 40:384–399
6.
Corrigan PW, Michaels PJ, Vega E, et al: Key ingredients to contact-based stigma change: a cross-validation. Psychiatr Rehabil J 2014; 37:62–64
7.
Thornicroft G, Mehta N, Clement S, et al: Evidence for effective interventions to reduce mental-health-related stigma and discrimination. Lancet 2016; 387:1123–1132
8.
Janoušková M, Tušková E, Weissová A, et al: Can video interventions be used to effectively destigmatize mental illness among young people? A systematic review. Eur Psychiatry 2017; 41:1–9
9.
Morgan AJ, Reavley NJ, Ross A, et al: Interventions to reduce stigma towards people with severe mental illness: systematic review and meta-analysis. J Psychiatr Res 2018; 103:120–133
10.
Corrigan P, Michaels PJ, Morris S: Do the effects of antistigma programs persist over time? Findings from a meta-analysis. Psychiatr Serv 2015; 66:543–546
11.
Amsalem D, Dixon LB, Neria Y: The COVID-19 outbreak and mental health: current risks and recommended actions. JAMA Psychiatry 2021;78:9–10
12.
Barney A, Buckelew S, Mesheriakova V, et al: The COVID-19 pandemic and rapid implementation of adolescent and young adult telemedicine: challenges and opportunities for innovation. J Adolesc Health 2020; 67:164–171
13.
NAMI in Our Own Voice. Arlington, VA, National Alliance on Mental Illness, n.d. https://www.nami.org/Support-Education/Mental-Health-Education/NAMI-In-Our-Own-Voice. Accessed Jan 15, 2022
14.
Jorm AF: Effect of contact-based interventions on stigma and discrimination: a critical examination of the evidence. Psychiatr Serv 2020; 71:735–737
15.
Griffiths KM, Carron-Arthur B, Parsons A, et al: Effectiveness of programs for reducing the stigma associated with mental disorders. A meta-analysis of randomized controlled trials. World Psychiatry 2014; 13:161–175
16.
Amsalem D, Yang LH, Jankowski S, et al: Reducing stigma toward individuals with schizophrenia using a brief video: a randomized controlled trial of young adults. Schizophr Bull 2021; 47:7–14
17.
Amsalem D, Markowitz JC, Jankowski SE, et al: Sustained effect of a brief video in reducing public stigma toward individuals with psychosis: a randomized controlled trial of young adults. Am J Psychiatry 2021; 178:635–642
18.
Amsalem D, Valeri L, Jankowski SE, et al: Reducing public stigma towards individuals with psychosis across race and gender: a randomized controlled trial of young adults. Schizophr Res 2022; 243:195–202
19.
Amsalem D, Martin A: Reducing depression‐related stigma and increasing treatment seeking among adolescents: randomized controlled trial of a brief video intervention. J Child Psychol Psychiatry 2022; 63:210–217
20.
Amsalem D, Halloran J, Penque B, et al: Effect of a brief social contact video on transphobia and depression-related stigma among adolescents: a randomized clinical trial. JAMA Netw Open 2022; 5:e220376
21.
Martin A, Calhoun A, Páez J, et al: Destigmatizing perceptions about Black adolescent depression: randomized controlled trial of brief social contact–based video interventions. J Child Psychol Psychiatry (Epub Jan 23, 2022). doi:
22.
Reinke RR, Corrigan PW, Leonhard C, et al: Examining two aspects of contact on the stigma of mental illness. J Soc Clin Psychol 2004; 23:377–389
23.
Vidal C, Lhaksampa T, Miller L, et al: Social media use and depression in adolescents: a scoping review. Int Rev Psychiatry 2020; 32:235–253
24.
Moses T: Self-labeling and its effects among adolescents diagnosed with mental disorders. Soc Sci Med 2009; 68:570–578
25.
Peer E, Brandimarte L, Samat S, et al: Beyond the Turk: alternative platforms for crowdsourcing behavioral research. J Exp Soc Psychol 2017; 70:153–163
26.
Chandler J, Rosenzweig C, Moss AJ, et al: Online panels in social science research: expanding sampling methods beyond Mechanical Turk. Behav Res Methods 2019; 51:2022–2038
27.
Boyd JE, Katz EP, Link BG, et al: The relationship of multiple aspects of stigma and personal contact with someone hospitalized for mental illness, in a nationally representative sample. Soc Psychiatry Psychiatr Epidemiol 2010; 45:1063–1070
28.
Phelan JC: Geneticization of deviant behavior and consequences for stigma: the case of mental illness. J Health Soc Behav 2005; 46:307–322
29.
Pescosolido BA, Monahan J, Link BG, et al: The public’s view of the competence, dangerousness, and need for legal coercion of persons with mental health problems. Am J Public Health 1999; 89:1339–1345
30.
Corrigan PW, Salzer M, Ralph RO, et al: Examining the factor structure of the Recovery Assessment Scale. Schizophr Bull 2004; 30:1035–1041
31.
Covarrubias I, Han M: Mental health stigma about serious mental illness among MSW students: social contact and attitude. Soc Work 2011; 56:317–325
32.
Griffiths KM, Christensen H, Jorm AF, et al: Effect of web-based depression literacy and cognitive-behavioural therapy interventions on stigmatising attitudes to depression: randomised controlled trial. Br J Psychiatry 2004; 185:342–349
33.
Wilson CJ, Deane FP, Marshall KL, et al: Reducing adolescents’ perceived barriers to treatment and increasing help-seeking intentions: effects of classroom presentations by general practitioners. J Youth Adolesc 2008; 37:1257–1269
34.
Arora S, Venkataraman V, ZhAn A, et al: Detecting and monitoring the symptoms of Parkinson’s disease using smartphones: a pilot study. Parkinsonism Relat Disord 2015; 21:650–653
35.
Madan Kumar PD, Mohandoss AA, Walls T, et al: Using smartphone video “selfies” to monitor change in toothbrushing behavior after a brief intervention: a pilot study. Indian J Dent Res 2016; 27:268–277
36.
Sellitto T, Ryan A, Judd T: ‘Video selfies’ for feedback and reflection. Med Educ 2016; 50:572–573
37.
Wang C, Burris MA: Photovoice: concept, methodology, and use for participatory needs assessment. Health Educ Behav 1997; 24:369–387
38.
Cabassa LJ, Nicasio A, Whitley R: Picturing recovery: a photovoice exploration of recovery dimensions among people with serious mental illness. Psychiatr Serv 2013; 64:837–842
39.
Tippin GK, Maranzan KA: Efficacy of a Photovoice‐based video as an online mental illness anti‐stigma intervention and the role of empathy in audience response: a randomized controlled trial. J Appl Soc Psychol 2019; 49:381–394
40.
Budenz A, Klassen A, Purtle J, et al: “If I was to post something, it would be too vulnerable:” university students and mental health disclosures on instagram. J Am Coll Health 2020; 70:615–624
41.
McGranahan R, Rennick-Egglestone S, Ramsay A, et al: Curation of mental health recovery narrative collections: systematic review and qualitative synthesis. JMIR Ment Health 2019; 6:e14233
42.
Berry N, Lobban F, Belousov M, et al: #WhyWeTweetMH: understanding why people use Twitter to discuss mental health problems. J Med Internet Res 2017; 19:e107
43.
Sinyor M, Williams M, Zaheer R, et al: The association between Twitter content and suicide. Aust N Z J Psychiatry 2021; 55:268–276
44.
Perinelli E, Gremigni P: Use of social desirability scales in clinical psychology: a systematic review. J Clin Psychol 2016; 72:534–551

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Psychiatric Services
Pages: 229 - 236
PubMed: 36254455

History

Received: 24 March 2022
Revision received: 7 May 2022
Revision received: 19 June 2022
Accepted: 25 June 2022
Published online: 18 October 2022
Published in print: March 01, 2023

Keywords

  1. Videos
  2. Social contact
  3. Treatment-seeking
  4. Psychosis
  5. Depression
  6. Stigma/discrimination

Authors

Details

Doron Amsalem, M.D. [email protected]
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
Samantha E. Jankowski, M.A.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
Shannon Pagdon, B.A.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
Linda Valeri, Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
Lawrence H. Yang, Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
John C. Markowitz, M.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
Yuval Neria, Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
Bernice A. Pescosolido, Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
Lisa B. Dixon, M.D., M.P.H.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).
Andrés Martin, M.D., Ph.D.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, and New York State Psychiatric Institute, New York City (Amsalem, Jankowski, Pagdon, Markowitz, Neria, Dixon); Department of Biostatistics (Valeri) and Department of Epidemiology (Yang), Columbia University Mailman School of Public Health, New York City; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York City (Yang); Department of Sociology, Indiana University, Bloomington (Pescosolido); Child Study Center and Simulated Participant Program, Yale School of Medicine, New Haven, Connecticut (Martin).

Notes

Send correspondence to Dr. Amsalem ([email protected]). Dr. Dixon is editor of the journal. Editor emeritus Howard H. Goldman, M.D., Ph.D., served as decision editor on the manuscript.

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share